Whalesbook
Liver Disease Ne Machaya Shor, Claims Hue Double!
Sabse pehle toh, Care Health Insurance ne bataya hai ki liver disease ke claims pichhle 3 saal mein double ho gaye hain. Aur treatment ka kharcha bhi lagbhag 100% tak badh gaya hai. Iske peeche kai reasons hain: zyada log affected ho rahe hain, diagnosis mein der ho rahi hai aur treatments bhi complex ho gaye hain. Young logo mein yeh cases 5-10% saalana badh rahe hain, aur Tier 2 & Tier 3 cities mein toh 10-15% saalana grow kar rahe hain. Ladies mein bhi claims 10% saalana badh rahe hain. Ministry of Health ke hisab se, MASLD (jo pehle NAFLD tha) 9% se 32% Indians ko affect kar raha hai, mainly lifestyle issues jaise obesity aur sedentary habits ke karan.
Kya Current Insurance Coverage Kaafi Hai?
Is situation mein, current health insurance coverage kaafi nahi lag raha hai. Ek ₹5 lakh ka sum insured jo pehle standard maana jaata tha, woh ab liver disease ke bade treatments ke liye kam pad raha hai, jo ₹10 lakh se bhi zyada ho sakte hain. Kuch experts bol rahe hain ki kam se kam ₹15 lakh ka cover aur upar se top-up plans ab zaroori ho gaye hain. Haalanki India mein sum insured levels badhe hain, par liver disease jaise chronic conditions ke badhte kharche general medical inflation se bhi zyada tezi se badh rahe hain. MASLD ko underwriting karna bhi mushkil hai kyunki yeh aksar pehle se existing condition maani jaati hai, jiske liye 2-3 saal ka waiting period ho sakta hai.
Insurers Ke Naye Plans Aur Wellness Programs
Ab insurers bhi active ho rahe hain. Woh preventive care aur wellness programs par focus kar rahe hain. Ismein regular health check-ups aur early diagnostics shamil hain diabetes, hypertension aur fatty liver jaise conditions ke liye, taaki time se intervention ho sake aur baad mein kharcha kam ho. Kai insurers diabetes aur heart ailments ke liye specialized products bana rahe hain jismein diagnostics, consultations aur wellness benefits milenge. Market mein holistic health management bhi badh raha hai, jahan insurers wellness-linked products laa rahe hain jo healthy habits maintain karne par rewards dete hain, jaise premium discounts ya reward points. Standalone health insurers apne products update karne aur digital services badhane par zor de rahe hain.
Industry Ke Liye Bade Risks
Lifestyle diseases jaise MASLD, insurers ke liye future claims predict karne mein ek bada risk bani hui hain. Yeh conditions, jo silent rehti hain aur metabolic syndrome, obesity se judi hain, India mein death ka ek major reason ban gayi hain, lagbhag 63% fatalities ka karan. Urbanization aur badalti diets isko aur kharab kar rahe hain, jis se frequent aur costly claims aa rahe hain, aur complications bhi badh rahi hain. Non-communicable diseases (NCDs) wale logon ke liye hospitalisation costs bahut zyada hoti hain. Jab insurance kam hota hai, toh log khud bada hissa pay karte hain, jisse financial problem hoti hai. Insurers ke liye is risk ko sahi se price karna difficult ho raha hai kyunki standard methods MASLD ke gradual development ko capture nahi kar paate. Ek aur concern hai adverse selection: low insurance penetration wale market mein, high-risk wale log symptoms dikhne par hi policy le sakte hain. Average claim payouts India mein FY23 se FY25 ke beech 30% tak badhne ki umeed hai, jiska reason medical inflation aur chronic illnesses ka badhna hai. Medical inflation 12-14% saalana hai. Isse incurred claims ratio (ICR) bhi affect ho sakta hai. For example, standalone health insurers ka ICR 68.73% tha FY24-25 mein, jo public sector insurers (100.59%) aur private general insurers (87.59%) se kam tha. Agar premiums claim costs ke hisaab se nahi badhe toh insurer profits ko nuksan ho sakta hai.
Aage Kya Ho Sakta Hai?
Long-term mein liver disease ka burden aur badhne ki forecasting hai. World Obesity Federation ka anuman hai ki agar current trends jaari rahe toh 2040 tak lagbhag 1.19 crore Indian bachche liver disease ke saath jee rahe honge. High incidence, badhti demographics aur higher treatment costs ke karan health insurance mein fundamental change ki zaroorat hai. Focus sirf hospitalisation cover se hatkar prevention, early detection aur adequate financial protection ki taraf ja raha hai NCDs ko manage karne ke liye. Indian health insurance market USD 62 billion tak pahunchne ki projection hai 2033 tak, 16.3% ke CAGR se. Ismein opportunity hai, par insurers ko apne products aur risk management strategies ko jaldi adapt karne ki zaroorat hai.